RTX Corporation : Back towards the lower end of the range
Entry price | Target | Stop-loss | Potential |
---|
US$95.97 |
US$104 |
US$92 |
+8.37% |
---|
After having been stuck in a trading range, shares in Raytheon Technologies Corporation are returning to the lower bound of the range phase. This appears to be a good opportunity for opening new positions.
Summary● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses● The company benefits from high valuations in earnings multiples.
● The company is highly valued given the cash flows generated by its activity.
● For the past year, analysts have significantly revised downwards their profit estimates.
● Over the past twelve months, analysts' opinions have been revised negatively.
● The company's earnings releases usually do not meet expectations.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.